Literature DB >> 2841944

Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease.

H R Schumacher1, S Magge, P V Cherian, J Sleckman, S Rothfuss, G Clayburne, M Sieck.   

Abstract

Studies by light microscopy on synovium obtained from 11 patients with Reiter's syndrome during the first month of an episode showed proliferation of synovial lining cells, polymorphonuclear neutrophils among the synovial lining cells, increased surface fibrin, and vascular congestion. Biopsy specimens taken later showed vascular congestion and still proliferated synovial lining cells, fewer polymorphonuclear neutrophils in some, and a tendency toward increased infiltration with lymphocytes and plasma cells. Electron microscopy of samples from 8 patients during the first month of disease activity showed occlusion of vessels by platelets in 4, and fibrin or dense granular material in the vessel walls in 4. Five of the patients with arthritis of less than 4 weeks duration had unidentified intracellular and extracellular particles; some of these were highly suggestive of Chlamydia. No such particles were noted in samples from patients with more chronic cases. Using an antibody to Chlamydia trachomatis and the peroxidase-antiperoxidase technique, immunocytochemistry showed reaction product in synovial macrophages in 2 patients with arthritis of less than 4 weeks duration, but not in the 1 patient studied who had more chronic disease. These studies provide support for dramatic synovial vascular injury consistent with that caused by endotoxin and the presence of chlamydial antigen in synovial macrophages, at least in the early phases of synovitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841944     DOI: 10.1002/art.1780310801

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  38 in total

Review 1.  Two forms of reactive arthritis?

Authors:  P Toivanen; A Toivanen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

2.  Reactive or infectious arthritis.

Authors:  J G Kuipers; L Köhler; H Zeidler
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 3.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 4.  Immunological basis of Chlamydia induced reactive arthritis.

Authors:  J S Gaston
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

5.  Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers.

Authors:  S Kotake; H R Schumacher; T K Arayssi; H C Gérard; P J Branigan; A P Hudson; C H Yarboro; J H Klippel; R L Wilder
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 6.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

Review 7.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Clinically silent infections in patients with oligoarthritis: results of a prospective study.

Authors:  C M Weyand; J J Goronzy
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

9.  Persistent infection of Chlamydia in reactive arthritis.

Authors:  M Rihl; L Köhler; A Klos; H Zeidler
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

10.  Long term follow up of SHR rats with experimental yersinia associated arthritis.

Authors:  R Merilahti-Palo; C Gripenberg-Lerche; K O Söderström; P Toivanen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.